New methodologies for old problems: tridimensional gastrointestinal organoids and guts-on-a-chip

Abstract

Objectives The present review intended to present a critical overview of the methodological and experimental advances concerning tridimensional cell culture models within the scope of gastrointestinal research. Methods A literature review was performed and some of the main published articles in the area were mentioned. Main results Classic studies and high impact results were presented, starting from the pioneer works with gastrointestinal organoids, with a small gut organoid, to the achievement of guts-on-a-chip and multi-organ-chips. It was also discussed which implications the construction of such co-cultures bring, as well as future applications arising from these new methodologies. Conclusions Despite the still discrete number of publications, in quantitative terms, there are qualitative promising and consistent results addressing physiopathological aspects and new therapeutic perspectives of tridimensional in vitro cultures in the gastroenterology field. It is expected, thus, that such new methodological approaches, including organoids and guts-on-a-chip, may contribute decisively to the advance in knowledge on basic aspects, as well as on the translation to new therapeutic approaches in gastrointestinal diseases.

Three-Dimensional Cell Cultures as a Research Platform in Lung Diseases and COVID-19

“…The use of such models dates back to around 500 B.C. and has allowed innumerable discoveries and advances in different areas of life sciences [50][51][52]. Some human diseases, however, still cannot be fully replicated in animals.…”

Leveraging and manufacturing in vitro multicellular spheroid-based tumor cell model as a preclinical tool for translating dysregulated tumor metabolism into clinical targets and biomarkers

“…The organ chip is a derivative technology of microfluidic chip, which serves to conduct micro-modeling of human organ structure on microfluidic cell culture chip, and to simulate the organ system activities, mechanical characteristics and physiological reactions. The biggest advantage of using this technology is to regulate the cell shape, function, location and physical and chemical microenvironment precisely (Sakalem and Ribeiro-Paes 2018). Organ chips have gradually replaced animal experiments and 2D culture for drug development and screening.…”

In Vitro 3D Cultures to Reproduce the Bone Marrow Niche

“…Animal models can provide a complex physiologic structure that is reasonably similar to the human cell and organ system. (34)(35)(36)(37) Although animal models can be adequately controlled and modified for pharmaceutical studies and discoveries, there are still challenges, such as species' differences, the high costs of animal model maintenance, and potential ethical issues. (30) According to a review by Alemany-Ribes and Semino, it is estimated to take 10 to 12 years to develop a new cancer drug, and only 5% of new drug applications receive approval from the U.S. Food and Drug Administration.…”